Skip to main content

Kintegral Advisory, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1569518 New York, NY

Position in GILD

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$14,541,354
-$1,499,714 QoQ
Shares Held
115,097
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
1.21%
of 13F equity value
Holder Rank
#372
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Kintegral Advisory, LLC holds $82,893,440 across 8 Drug Manufacturers - General names. GILD ranks #2 (17.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 GILD
Gilead Sciences, Inc.
This page
115,097 $14,541,354

All Filings in GILD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,541,354 115,097
2026-03-31 $16,041,068 115,097
2025-12-31 $14,753,348 120,200
2025-09-30 $13,707,390 123,490
2025-06-30 $13,752,536 124,042
2025-03-31 $13,919,859 124,229
2024-12-31 $11,513,551 124,646
2024-09-30 $10,937,179 130,453
2024-06-30 $9,067,634 132,162
2024-03-31 $5,915,596 80,759
2023-12-31 $6,562,701 81,011
2023-09-30 $6,109,633 81,527
2023-06-30 $6,286,985 81,575
2023-03-31 $6,768,277 81,575
2022-12-31 $7,379,494 85,958
2022-09-30 $2,897,085 46,962
2022-06-30 $2,902,721 46,962
2022-03-31 $2,732,797 45,968
2021-12-31 $3,263,093 44,940
2021-09-30 $3,139,059 44,940
2021-06-30 $3,094,568 44,940
2021-03-31 $2,904,472 44,940
2020-12-31 $2,618,204 44,940
2020-09-30 $2,839,758 44,940
2020-06-30 $3,568,938 46,386
2020-03-31 $3,467,817 46,386